- Page 8:
❘❙❚■ ContributorsStephen L
- Page 11 and 12:
Clinical Trials: A Practical Guide
- Page 13 and 14:
Clinical Trials: A Practical Guide
- Page 15:
Clinical Trials: A Practical Guide
- Page 19 and 20:
■■❚❙❘Chapter 1RandomizedC
- Page 21 and 22:
Clinical Trials: A Practical Guide
- Page 23 and 24:
Clinical Trials: A Practical Guide
- Page 25 and 26:
Clinical Trials: A Practical Guide
- Page 27 and 28:
Clinical Trials: A Practical Guide
- Page 29 and 30:
Clinical Trials: A Practical Guide
- Page 31:
Clinical Trials: A Practical Guide
- Page 34 and 35:
❘❙❚■ Chapter 2 | Uncontroll
- Page 36 and 37:
❘❙❚■ Chapter 2 | Uncontroll
- Page 38 and 39:
❘❙❚■ Chapter 2 | Uncontroll
- Page 41 and 42:
■■❚❙❘Chapter 3Protocol De
- Page 43 and 44:
Clinical Trials: A Practical Guide
- Page 45 and 46:
Clinical Trials: A Practical Guide
- Page 47 and 48:
Clinical Trials: A Practical Guide
- Page 49 and 50:
Clinical Trials: A Practical Guide
- Page 51 and 52:
Clinical Trials: A Practical Guide
- Page 53 and 54:
Clinical Trials: A Practical Guide
- Page 55 and 56: ■■❚❙❘Chapter 4EndpointsAm
- Page 57 and 58: Clinical Trials: A Practical Guide
- Page 59 and 60: Clinical Trials: A Practical Guide
- Page 61 and 62: Clinical Trials: A Practical Guide
- Page 63 and 64: Clinical Trials: A Practical Guide
- Page 65 and 66: ■■❚❙❘Chapter 5Patient Sel
- Page 67 and 68: Clinical Trials: A Practical Guide
- Page 69 and 70: Clinical Trials: A Practical Guide
- Page 71 and 72: Clinical Trials: A Practical Guide
- Page 73 and 74: ■■❚❙❘Chapter 6Source and
- Page 75 and 76: Clinical Trials: A Practical Guide
- Page 77 and 78: Clinical Trials: A Practical Guide
- Page 79 and 80: Clinical Trials: A Practical Guide
- Page 81 and 82: Clinical Trials: A Practical Guide
- Page 83 and 84: ■■❚❙❘Chapter 7Randomizati
- Page 85 and 86: Clinical Trials: A Practical Guide
- Page 87 and 88: Clinical Trials: A Practical Guide
- Page 89 and 90: Clinical Trials: A Practical Guide
- Page 91: Clinical Trials: A Practical Guide
- Page 94 and 95: ❘❙❚■ Chapter 8 | BlindingBl
- Page 96 and 97: ❘❙❚■ Chapter 8 | BlindingTh
- Page 98 and 99: ❘❙❚■ Chapter 8 | BlindingAs
- Page 100 and 101: ❘❙❚■ Chapter 9 | Sample Siz
- Page 102 and 103: ❘❙❚■ Chapter 9 | Sample Siz
- Page 104 and 105: ❘❙❚■ Chapter 9 | Sample Siz
- Page 109 and 110: ■■❚❙❘Chapter 10Crossover
- Page 111 and 112: Clinical Trials: A Practical Guide
- Page 113 and 114: Clinical Trials: A Practical Guide
- Page 115 and 116: Clinical Trials: A Practical Guide
- Page 117 and 118: Clinical Trials: A Practical Guide
- Page 119 and 120: ■■❚❙❘Chapter 11Factorial
- Page 121 and 122: Clinical Trials: A Practical Guide
- Page 123 and 124: Clinical Trials: A Practical Guide
- Page 125 and 126: Clinical Trials: A Practical Guide
- Page 127 and 128: Clinical Trials: A Practical Guide
- Page 129 and 130: Clinical Trials: A Practical Guide
- Page 131 and 132: ■■❚❙❘Chapter 12Equivalenc
- Page 133 and 134: Clinical Trials: A Practical Guide
- Page 135 and 136: Clinical Trials: A Practical Guide
- Page 137 and 138: ■■❚❙❘Chapter 13Bioequival
- Page 139 and 140: Clinical Trials: A Practical Guide
- Page 141 and 142: Clinical Trials: A Practical Guide
- Page 143 and 144: Clinical Trials: A Practical Guide
- Page 145 and 146: Clinical Trials: A Practical Guide
- Page 147 and 148: Clinical Trials: A Practical Guide
- Page 149 and 150: ■■❚❙❘Chapter 14Noninferio
- Page 151 and 152: Clinical Trials: A Practical Guide
- Page 153 and 154: Clinical Trials: A Practical Guide
- Page 155 and 156: Clinical Trials: A Practical Guide
- Page 157 and 158:
Clinical Trials: A Practical Guide
- Page 159 and 160:
■■❚❙❘Chapter 15Cluster Ra
- Page 161 and 162:
Clinical Trials: A Practical Guide
- Page 163 and 164:
Clinical Trials: A Practical Guide
- Page 165 and 166:
Clinical Trials: A Practical Guide
- Page 167 and 168:
Clinical Trials: A Practical Guide
- Page 169 and 170:
Clinical Trials: A Practical Guide
- Page 171 and 172:
■■❚❙❘Chapter 16Multicente
- Page 173 and 174:
Clinical Trials: A Practical Guide
- Page 175 and 176:
Clinical Trials: A Practical Guide
- Page 177 and 178:
Clinical Trials: A Practical Guide
- Page 179 and 180:
Clinical Trials: A Practical Guide
- Page 181:
Clinical Trials: A Practical Guide
- Page 184 and 185:
166
- Page 186 and 187:
❘❙❚■ Chapter 17 | Types of
- Page 188 and 189:
❘❙❚■ Chapter 17 | Types of
- Page 190 and 191:
❘❙❚■ Chapter 17 | Types of
- Page 192 and 193:
❘❙❚■ Chapter 17 | Types of
- Page 194 and 195:
❘❙❚■ Chapter 17 | Types of
- Page 196 and 197:
❘❙❚■ Chapter 17 | Types of
- Page 198 and 199:
❘❙❚■ Chapter 17 | Types of
- Page 200 and 201:
❘❙❚■ Chapter 17 | Types of
- Page 202 and 203:
❘❙❚■ Chapter 17 | Types of
- Page 204 and 205:
❘❙❚■ Chapter 18 | Significa
- Page 206 and 207:
❘❙❚■ Chapter 18 | Significa
- Page 208 and 209:
❘❙❚■ Chapter 18 | Significa
- Page 210 and 211:
❘❙❚■ Chapter 18 | Significa
- Page 212 and 213:
❘❙❚■ Chapter 18 | Significa
- Page 214 and 215:
❘❙❚■ Chapter 18 | Significa
- Page 216 and 217:
❘❙❚■ Chapter 19 | Compariso
- Page 218 and 219:
❘❙❚■ Chapter 19 | Compariso
- Page 220 and 221:
❘❙❚■ Chapter 19 | Compariso
- Page 222 and 223:
❘❙❚■ Chapter 19 | Compariso
- Page 224 and 225:
❘❙❚■ Chapter 19 | Compariso
- Page 226 and 227:
❘❙❚■ Chapter 19 | Compariso
- Page 228 and 229:
❘❙❚■ Chapter 19 | Compariso
- Page 230 and 231:
❘❙❚■ Chapter 19 | Compariso
- Page 232 and 233:
❘❙❚■ Chapter 19 | Compariso
- Page 234 and 235:
216
- Page 236 and 237:
❘❙❚■ Chapter 20 | Compariso
- Page 238 and 239:
❘❙❚■ Chapter 20 | Compariso
- Page 240 and 241:
❘❙❚■ Chapter 20 | Compariso
- Page 242 and 243:
❘❙❚■ Chapter 20 | Compariso
- Page 244 and 245:
❘❙❚■ Chapter 20 | Compariso
- Page 246 and 247:
❘❙❚■ Chapter 20 | Compariso
- Page 248 and 249:
❘❙❚■ Chapter 20 | Compariso
- Page 250 and 251:
❘❙❚■ Chapter 20 | Compariso
- Page 252 and 253:
234
- Page 254 and 255:
❘❙❚■ Chapter 21 | Analysis
- Page 256 and 257:
❘❙❚■ Chapter 21 | Analysis
- Page 258 and 259:
❘❙❚■ Chapter 21 | Analysis
- Page 260 and 261:
❘❙❚■ Chapter 21 | Analysis
- Page 262 and 263:
❘❙❚■ Chapter 21 | Analysis
- Page 264 and 265:
❘❙❚■ Chapter 21 | Analysis
- Page 266 and 267:
❘❙❚■ Chapter 21 | Analysis
- Page 268 and 269:
❘❙❚■ Chapter 21 | Analysis
- Page 270 and 271:
❘❙❚■ Chapter 21 | Analysis
- Page 272 and 273:
254
- Page 274 and 275:
❘❙❚■ Chapter 22 | Intention
- Page 276 and 277:
❘❙❚■ Chapter 22 | Intention
- Page 278 and 279:
❘❙❚■ Chapter 22 | Intention
- Page 280 and 281:
❘❙❚■ Chapter 22 | Intention
- Page 282 and 283:
264
- Page 284 and 285:
❘❙❚■ Chapter 23 | Subgroup
- Page 286 and 287:
❘❙❚■ Chapter 23 | Subgroup
- Page 288 and 289:
❘❙❚■ Chapter 23 | Subgroup
- Page 290 and 291:
272
- Page 292 and 293:
❘❙❚■ Chapter 24 | Regressio
- Page 294 and 295:
❘❙❚■ Chapter 24 | Regressio
- Page 296 and 297:
❘❙❚■ Chapter 24 | Regressio
- Page 298 and 299:
❘❙❚■ Chapter 24 | Regressio
- Page 300 and 301:
❘❙❚■ Chapter 24 | Regressio
- Page 302 and 303:
❘❙❚■ Chapter 24 | Regressio
- Page 304 and 305:
286
- Page 306 and 307:
❘❙❚■ Chapter 25 | Adjustmen
- Page 308 and 309:
❘❙❚■ Chapter 25 | Adjustmen
- Page 310 and 311:
❘❙❚■ Chapter 25 | Adjustmen
- Page 312 and 313:
❘❙❚■ Chapter 25 | Adjustmen
- Page 314 and 315:
❘❙❚■ Chapter 26 | Confoundi
- Page 316 and 317:
❘❙❚■ Chapter 26 | Confoundi
- Page 318 and 319:
❘❙❚■ Chapter 26 | Confoundi
- Page 320 and 321:
❘❙❚■ Chapter 26 | Confoundi
- Page 322 and 323:
❘❙❚■ Chapter 26 | Confoundi
- Page 324 and 325:
❘❙❚■ Chapter 27 | Interacti
- Page 326 and 327:
❘❙❚■ Chapter 27 | Interacti
- Page 328 and 329:
❘❙❚■ Chapter 27 | Interacti
- Page 330 and 331:
❘❙❚■ Chapter 27 | Interacti
- Page 332 and 333:
❘❙❚■ Chapter 27 | Interacti
- Page 334 and 335:
❘❙❚■ Chapter 27 | Interacti
- Page 336 and 337:
❘❙❚■ Chapter 28 | Repeated
- Page 338 and 339:
❘❙❚■ Chapter 28 | Repeated
- Page 340 and 341:
❘❙❚■ Chapter 28 | Repeated
- Page 342 and 343:
❘❙❚■ Chapter 28 | Repeated
- Page 344 and 345:
❘❙❚■ Chapter 28 | Repeated
- Page 346 and 347:
❘❙❚■ Chapter 28 | Repeated
- Page 348 and 349:
❘❙❚■ Chapter 29 | Multiplic
- Page 350 and 351:
❘❙❚■ Chapter 29 | Multiplic
- Page 352 and 353:
❘❙❚■ Chapter 29 | Multiplic
- Page 354 and 355:
❘❙❚■ Chapter 29 | Multiplic
- Page 356 and 357:
❘❙❚■ Chapter 29 | Multiplic
- Page 358 and 359:
❘❙❚■ Chapter 30 | Missing D
- Page 360 and 361:
❘❙❚■ Chapter 30 | Missing D
- Page 362 and 363:
❘❙❚■ Chapter 30 | Missing D
- Page 364 and 365:
❘❙❚■ Chapter 30 | Missing D
- Page 366 and 367:
❘❙❚■ Chapter 30 | Missing D
- Page 368 and 369:
❘❙❚■ Chapter 30 | Missing D
- Page 370 and 371:
352
- Page 372 and 373:
❘❙❚■ Chapter 31 | Interim M
- Page 374 and 375:
❘❙❚■ Chapter 31 | Interim M
- Page 376 and 377:
❘❙❚■ Chapter 31 | Interim M
- Page 378 and 379:
❘❙❚■ Chapter 31 | Interim M
- Page 380 and 381:
❘❙❚■ Chapter 31 | Interim M
- Page 382 and 383:
364
- Page 384 and 385:
❘❙❚■ Chapter 32 | Overview
- Page 386 and 387:
❘❙❚■ Chapter 32 | Overview
- Page 388 and 389:
❘❙❚■ Chapter 32 | Overview
- Page 390 and 391:
❘❙❚■ Chapter 32 | Overview
- Page 392 and 393:
❘❙❚■ Chapter 32 | Overview
- Page 394 and 395:
376
- Page 396 and 397:
❘❙❚■ Chapter 33 | Trial Pro
- Page 398 and 399:
❘❙❚■ Chapter 33 | Trial Pro
- Page 400 and 401:
❘❙❚■ Chapter 33 | Trial Pro
- Page 402 and 403:
❘❙❚■ Chapter 33 | Trial Pro
- Page 404 and 405:
❘❙❚■ Chapter 34 | Presentin
- Page 406 and 407:
❘❙❚■ Chapter 34 | Presentin
- Page 408 and 409:
❘❙❚■ Chapter 34 | Presentin
- Page 410 and 411:
❘❙❚■ Chapter 35 | Use of Ta
- Page 412 and 413:
❘❙❚■ Chapter 35 | Use of Ta
- Page 414 and 415:
❘❙❚■ Chapter 35 | Use of Ta
- Page 416 and 417:
❘❙❚■ Chapter 35 | Use of Ta
- Page 418 and 419:
❘❙❚■ Chapter 35 | Use of Ta
- Page 420 and 421:
❘❙❚■ Chapter 35 | Use of Ta
- Page 422 and 423:
❘❙❚■ Chapter 35 | Use of Ta
- Page 424 and 425:
406
- Page 426 and 427:
❘❙❚■ Chapter 36 | Use of Fi
- Page 428 and 429:
❘❙❚■ Chapter 36 | Use of Fi
- Page 430 and 431:
❘❙❚■ Chapter 36 | Use of Fi
- Page 432 and 433:
❘❙❚■ Chapter 36 | Use of Fi
- Page 434 and 435:
❘❙❚■ Chapter 36 | Use of Fi
- Page 436 and 437:
❘❙❚■ Chapter 36 | Use of Fi
- Page 438 and 439:
❘❙❚■ Chapter 36 | Use of Fi
- Page 440 and 441:
❘❙❚■ Chapter 36 | Use of Fi
- Page 442 and 443:
❘❙❚■ Chapter 36 | Use of Fi
- Page 444 and 445:
426
- Page 446 and 447:
❘❙❚■ Chapter 37 | Critical
- Page 448 and 449:
❘❙❚■ Chapter 37 | Critical
- Page 450 and 451:
❘❙❚■ Chapter 37 | Critical
- Page 452 and 453:
❘❙❚■ Chapter 37 | Critical
- Page 454 and 455:
❘❙❚■ Chapter 37 | Critical
- Page 456 and 457:
438
- Page 458 and 459:
❘❙❚■ Chapter 38 | Meta-Anal
- Page 460 and 461:
❘❙❚■ Chapter 38 | Meta-Anal
- Page 462 and 463:
❘❙❚■ Chapter 38 | Meta-Anal
- Page 464 and 465:
❘❙❚■ Chapter 38 | Meta-Anal
- Page 466 and 467:
❘❙❚■ Chapter 38 | Meta-Anal
- Page 468 and 469:
❘❙❚■ Chapter 38 | Meta-Anal
- Page 470 and 471:
452
- Page 472 and 473:
❘❙❚■ GlossaryANOVA (analysi
- Page 474 and 475:
❘❙❚■ GlossaryHazard ratioIn
- Page 476 and 477:
❘❙❚■ GlossaryPer-protocol a
- Page 478 and 479:
460
- Page 480 and 481:
❘❙❚■ Abbreviations3TCACEALL
- Page 482 and 483:
❘❙❚■ AbbreviationsMDCMERIT-
- Page 484 and 485:
466
- Page 486 and 487:
❘❙❚■ IndexNote: Page number
- Page 488 and 489:
❘❙❚■ Indexstratified random
- Page 490 and 491:
❘❙❚■ IndexHhazard function,
- Page 492 and 493:
❘❙❚■ Indexsignificance effe
- Page 494 and 495:
❘❙❚■ IndexQqualitative inte
- Page 496 and 497:
❘❙❚■ Indexpopulation, 186,
- Page 498:
❘❙❚■ Indexwithin-subject va